Overview
Compare with FREQUENCY ELECTRONICS INC, INTEST CORP or Data I/O, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2026
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Systems brought in 57% of the revenue Aehr Test Systems broke down this way in fiscal 2026.
Products and services by year
| Products and services | 2024 | 2025 | 2026 |
|---|---|---|---|
| Systems | $24.2M | $22.0M | $28.7M |
| Contactors | $37.6M | $30.8M | $14.9M |
| Services [member] | $4.5M | $6.1M | $6.4M |
Regions
Asiia brought in 46% of the revenue Aehr Test Systems broke down this way in fiscal 2026.
Regions by year
| Regions | 2024 | 2025 | 2026 |
|---|---|---|---|
| Asiia | $58.1M | $37.1M | $22.8M |
| Uniited States | $3.5M | $17.7M | $20.6M |
| Europe and Miiddle East | $4.6M | $4.2M | $6.5M |
Where the money goes
Where each dollar of revenue went, fiscal 2026
- Cost of revenue47¢$32.4M
- Research and development18¢$12.6M
- Selling, general and admin28¢$19.2M
- Income tax7¢$4.6M
Out of $50.0M in revenue.4 The company lost money this year.
Financial statements
Every line of the income statement in the latest annual report, as filed.4
| Period ending | 2026-05-31 | 2025-05-31 | 2024-05-31 |
|---|---|---|---|
| Revenue | $50.0M | $59.0M | $66.2M |
| Cost of revenue | $32.4M | $35.0M | $33.7M |
| Gross profit | $17.7M | $23.9M | $32.5M |
| Research and development | $12.6M | $10.5M | $8.7M |
| Selling, general and administrative | $19.2M | $18.3M | $13.7M |
| Restructuring charges | $6.0K | $864.0K | $0 |
| Total operating expenses | $31.8M | $29.6M | $22.5M |
| Income (loss) from operations | -$14.1M | -$5.7M | $10.1M |
| Interest income, net | $1.4M | $1.4M | $2.4M |
| Other income (expense), net | $1.1M | -$15.0K | -$8.0K |
| Income (loss) before income tax benefit | -$11.7M | -$4.3M | $12.5M |
| Income tax benefit | -$4.6M | -$381.0K | -$20.7M |
| Net income (loss) | -$7.1M | -$3.9M | $33.2M |
| Basic | -$0.23 | -$0.13 | $1.15 |
| Diluted | -$0.23 | -$0.13 | $1.12 |
| Basic | 30.7M shares | 29.6M shares | 28.8M shares |
| Diluted | 30.7M shares | 29.6M shares | 29.6M shares |
Every line of the balance sheet in the latest annual report, as filed.4
| Period ending | 2026-05-31 | 2025-05-31 | 2024-05-31 |
|---|---|---|---|
| Cash and cash equivalents | $116.4M | $24.5M | |
| Accounts receivable | $17.5M | $14.2M | |
| Inventories | $41.4M | $42.0M | |
| Prepaid expenses and other current assets | $9.3M | $8.1M | |
| Total current assets | $184.4M | $88.8M | |
| Property and equipment, net | $8.9M | $9.0M | |
| Goodwill | $10.7M | $10.7M | |
| Intangible assets, net | $9.6M | $10.8M | |
| Deferred tax assets, net | $23.8M | $19.1M | |
| Operating lease right-of-use assets, net | $8.9M | $9.6M | |
| Other non-current assets | $305.0K | $546.0K | |
| Total assets | $246.7M | $148.5M | |
| Accounts payable | $6.8M | $6.7M | |
| Accrued expenses and other current liabilities | $5.3M | $6.0M | |
| Operating lease liabilities, short-term | $626.0K | $909.0K | |
| Deferred revenue, short-term | $5.2M | $2.0M | |
| Total current liabilities | $17.9M | $15.6M | |
| Operating lease liabilities, long-term | $9.3M | $9.9M | |
| Deferred revenue, long-term | $34.0K | $36.0K | |
| Other long-term liabilities | $38.0K | $42.0K | |
| Total liabilities | $27.2M | $25.6M | |
| Preferred stock, $0.01 par value: Authorized: 10,000 shares; Issued and outstanding: none | $0 | $0 | |
| Common stock, $0.01 par value: Authorized: 75,000 shares; Issued and outstanding: 32,480 shares and 29,877 shares at May 29, 2026 and May 30, 2025, respectively | $325.0K | $299.0K | |
| Additional paid-in capital | $249.5M | $145.8M | |
| Accumulated other comprehensive loss | -$105.0K | -$126.0K | -$158.0K |
| Accumulated deficit | -$30.2M | -$23.1M | |
| Total shareholders' equity | $219.5M | $122.9M | $111.6M |
| Total liabilities and shareholders equity | $246.7M | $148.5M | |
| Preferred stock, par value | $0.01 | $0.01 | |
| Preferred stock, shares authorized | 10.0M shares | 10.0M shares | |
| Preferred stock, shares issued | 0 shares | 0 shares | |
| Preferred stock, shares outstanding | 0 shares | 0 shares | |
| Common stock, par value | $0.01 | $0.01 | |
| Common stock, shares authorized | 75.0M shares | 75.0M shares | |
| Common stock, shares issued | 32.5M shares | 29.9M shares | |
| Common stock, shares outstanding | 32.5M shares | 29.9M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.4
| Period ending | 2026-05-31 | 2025-05-31 | 2024-05-31 |
|---|---|---|---|
| Net income (loss) | -$7.1M | -$3.9M | $33.2M |
| Stock-based compensation expense | $6.8M | $5.2M | $2.5M |
| Depreciation and amortization | $2.8M | $2.3M | $657.0K |
| Deferred income taxes | -$4.7M | -$421.0K | -$20.8M |
| Amortization of operating lease right-of-use assets | $731.0K | $1.1M | $706.0K |
| Impairment of assets | $0 | $584.0K | $0 |
| Accretion of investment discount | $0 | $0 | -$130.0K |
| Accounts receivable | -$3.3M | -$3.0M | $6.8M |
| Inventories | $11.0K | -$2.4M | -$13.7M |
| Prepaid expenses and other assets | -$2.8M | -$5.0M | -$875.0K |
| Accounts payable | $991.0K | -$714.0K | -$3.9M |
| Accrued expenses | $1.0M | -$378.0K | -$792.0K |
| Deferred revenue | $3.2M | $143.0K | -$1.5M |
| Operating lease liabilities | -$979.0K | -$699.0K | -$423.0K |
| Income taxes payable | $58.0K | -$65.0K | $14.0K |
| Net cash provided by (used in) operating activities | -$3.3M | -$7.4M | $1.8M |
| Purchases of property and equipment | -$2.1M | -$5.0M | -$749.0K |
| Proceeds from maturities of investments | $0 | $0 | $18.0M |
| Payments for business acquisition, net of cash and cash equivalent acquired | -$1.8M | -$11.1M | $0 |
| Net cash provided by (used in) investing activities | -$3.9M | -$16.1M | $17.3M |
| Proceeds from issuance of common stock from public offerings, net of issuance costs | $97.4M | $0 | -$72.0K |
| Proceeds from issuance of common stock under employee plans | $2.2M | $1.4M | $1.8M |
| Shares repurchased for tax withholdings on vesting of restricted stock units, amount | -$2.4M | -$784.0K | -$1.6M |
| Net cash provided by financing activities | $97.2M | $625.0K | $139.0K |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -$6.0K | $13.0K | -$41.0K |
| Net increase (decrease) in cash, cash equivalents and restricted cash | $90.0M | -$22.8M | $19.1M |
| Income taxes paid | $60.0K | $100.0K | $90.0K |
| Interest paid | $0 | $0 | $0 |
| Net transfer of equipment between inventory and property and equipment | $702.0K | $458.0K | $357.0K |
| Purchases of property and equipment included in accounts payable and accrued liabilities | $0 | $1.3M | $53.0K |
| Common stock issuance costs included in accounts payable | $296.0K | $0 | $0 |
Recent filings
- Oct 13, 20264 PRIMARY DOCUMENT
- Oct 13, 20264 PRIMARY DOCUMENT
- Oct 13, 20264 PRIMARY DOCUMENT
- Oct 13, 20264 PRIMARY DOCUMENT
- Oct 13, 20264 PRIMARY DOCUMENT
- Oct 13, 20264 PRIMARY DOCUMENT
- Oct 5, 20264 PRIMARY DOCUMENT
- Oct 5, 20264 PRIMARY DOCUMENT
- Oct 5, 20264 PRIMARY DOCUMENT
- Oct 5, 20264 PRIMARY DOCUMENT
- Oct 5, 20264 PRIMARY DOCUMENT
- Oct 5, 20264 PRIMARY DOCUMENT
- Oct 5, 20264 PRIMARY DOCUMENT
- Oct 2, 20264 PRIMARY DOCUMENT
- Oct 2, 20264 PRIMARY DOCUMENT
Every filing from the last three years, summarized. The full record is on SEC EDGAR.2
Links
- Websitewww.aehr.com1
- LinkedInwww.linkedin.com/company/aehr-test-systems1
- WikidataQ124224170
- SEC EDGARCIK 1040470
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataAehr Test Systems on Wikidata
- 2
- 3Company websiteAehr Test Systems logo
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14